文献速递呼吸衰竭与机械通气儿科与产科急症

支气管肺发育不良早产儿与足月或近足月婴儿的膈肌厚度与移动度:一项前瞻性观察性研究

Diaphragmatic Thickness and Excursion in Preterm Infants With Bronchopulmonary Dysplasia Compared With Term or Near Term Infants: A Prospective Observational Study.
PubMed 文献 · Chest · 2022-08-10
一句话结论与健康足月或近足月婴儿相比,支气管肺发育不良早产儿呼气末膈肌厚度更低,而膈肌增厚分数和移动度更高。

这项前瞻性观察性病例对照研究纳入111例婴儿,其中56例支气管肺发育不良早产儿(研究时平均年龄37.7±1.7周)与55例健康对照(平均年龄38.1±1.5周),用床旁超声测量呼气末膈肌厚度(DTexp)、吸气末膈肌厚度(DTins)、膈肌增厚分数(DTF)和膈肌移动度(DE),并按体表面积(BSA)校正体型差异。结果显示,支气管肺发育不良组DTexp和DTexp/BSA比值均显著低于健康对照组(1.3±0.4 mm vs 1.5±0.4 mm,P=0.01;7.1±1.4 mm/m² vs 7.8±1.8 mm/m²,P=0.03),而DTF和DE显著高于对照组(61.8±26.0 vs 43.3±19.7,P<0.01;6.0±1.7 mm vs 4.4±1.6 mm,P<0.01)。作者认为,未来研究需要关注伴或不伴支气管肺发育不良的早产儿膈肌尺寸的演变。

要点

  • 支气管肺发育不良早产儿呼气末膈肌厚度低于健康对照(1.3±0.4 mm vs 1.5±0.4 mm,P=0.01)。
  • 按体表面积校正后,支气管肺发育不良组DTexp/BSA仍低于对照组(7.1±1.4 mm/m² vs 7.8±1.8 mm/m²,P=0.03)。
  • 支气管肺发育不良组膈肌增厚分数高于健康对照(61.8±26.0 vs 43.3±19.7,P<0.01)。
  • 支气管肺发育不良组膈肌移动度高于健康对照(6.0±1.7 mm vs 4.4±1.6 mm,P<0.01)。
  • 作者认为,未来研究需要关注伴或不伴支气管肺发育不良的早产儿膈肌尺寸的演变。

适用人群与场景

  • 胎龄小于32周的早产儿,研究时平均年龄37.7±1.7周,诊断为支气管肺发育不良(患者组)。
  • 健康、月经后年龄匹配的晚期早产儿或足月儿(对照组),平均年龄38.1±1.5周。

研究设计与关键结果

  • 研究类型为前瞻性观察性病例对照研究,纳入111例婴儿,包括56例支气管肺发育不良早产儿和55例健康对照。
  • 床旁超声测量呼气末膈肌厚度(DTexp)、吸气末膈肌厚度(DTins)、膈肌增厚分数(DTF)和膈肌移动度(DE),并按体表面积(BSA)校正。
  • DTexp:支气管肺发育不良组1.3±0.4 mm vs 健康对照组1.5±0.4 mm,P=0.01。
  • DTexp/BSA:支气管肺发育不良组7.1±1.4 mm/m² vs 健康对照组7.8±1.8 mm/m²,P=0.03。
  • DTF:支气管肺发育不良组61.8±26.0 vs 健康对照组43.3±19.7,P<0.01。
  • DE:支气管肺发育不良组6.0±1.7 mm vs 健康对照组4.4±1.6 mm,P<0.01。

证据类型、等级与局限

  • 证据类型:前瞻性观察性病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 床旁超声可测量早产儿膈肌厚度、增厚分数和移动度,并按体表面积校正体型差异。
  • 在支气管肺发育不良早产儿中,呼气末膈肌厚度更低,而膈肌增厚分数和移动度更高,解读膈肌超声时应结合支气管肺发育不良状态。
  • 作者认为,未来研究需要关注伴或不伴支气管肺发育不良的早产儿膈肌尺寸的演变。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Diaphragmatic atrophy associated with mechanical ventilation is reported in pediatric and adult patients, but a similar association has not been described in preterm infants with bronchopulmonary dysplasia (BPD).

RESEARCH QUESTION: Does BPD impact the diaphragm thickness (DT) and diaphragm excursion (DE) in infants born before 32 weeks' gestation compared with healthy late preterm or term infants?

STUDY DESIGN AND METHODS: In this prospective observational case-control study, DT at end of expiration (DTexp), DT at end of inspiration (DTins), DT fraction (DTF), and DE (DE) were assessed using bedside ultrasound. Two groups were compared: infants with BPD (patients) and healthy, postmenstrual age-matched infants (control participants). To account for variations in body size between groups, diaphragmatic measurements were expressed as a ratio of body surface area (BSA). Statistical analyses were conducted using SAS software version 9.4 (SAS Institute, Inc.).

RESULTS: We enrolled 111 infants, including 56 preterm infants with BPD (mean ± SD study age, 37.7 ± 1.7 weeks) and 55 healthy control participants (mean ± SD study age, 38.1 ± 1.5 weeks). DTexp and DTexp to BSA ratio were significantly lower in the BPD group compared with the healthy control group (mean ± SD, 1.3 ± 0.4 mm vs 1.5 ± 0.4 mm [P = .01] and 7.1 ± 1.4 mm/m2 vs 7.8 ± 1.8 mm/m2 [P = .03]). DTF and DE were significantly higher in the BPD group vs the healthy control group (mean ± SD, 61.8 ± 26.0 vs 43.3 ± 19.7 [P < .01] and 6.0 ± 1.7 mm vs 4.4 ± 1.6 mm [P < .01], respectively).

INTERPRETATION: In infants with BPD, DTexp was significantly lower, whereas DTF and DE were significantly higher, compared with healthy, age-matched control participants. Future studies are required and should focus on describing the evolution of diaphragmatic dimensions in preterm infants with and without BPD.

TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT04941963; URL: www.

CLINICALTRIALS: gov.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Yeung T, Mohsen N, Ghanem M, et al. Diaphragmatic Thickness and Excursion in Preterm Infants With Bronchopulmonary Dysplasia Compared With Term or Near Term Infants: A Prospective Observational Study. Chest. 2022. PMID: 35963296. doi:10.1016/j.chest.2022.08.003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。